Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Regulation & Policy Market Research Reports

Titlepublishedprice

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016

By GlobalData
"...... ships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing r......"
01-Apr-2017$1500

Global Big Pharma Partnering Terms and Agreements 2010-2017: Deal trends, players and financials

By Current Partnering
"...... rma partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes. This report provides details of the latest Big Pharma agreements announced in the life sciences......"
01-Apr-2017$2995

Global Pharmerging Contract Manufacturings Market Size, Status and Forecast 2022

By QYResearch Group
"...... ike - Cipla - Piramal Healthcare - Aurobindo - Jubilant Life Sciences - Zydus Cadila - Alkem - Intas - Lupin - Torrent - FDC Market segment by Regions/Countries, thi......"
09-Mar-2017$3300

Partnerships, Licensing, Investments and M&A Deals and Trends for January 2017 in Pharmaceuticals

By GlobalData
"...... is on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and ventur......"
07-Mar-2017$1000

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

By Current Partnering
"...... ntered into by the worlds leading healthcare companies. The Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides details of the latest merger and acquisition (M&A) agreements a......"
01-Mar-2017$2995

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Japan

By GlobalData
"...... eneric substitution and yearly pricing reviews are likely to restrict growth in the Japanese pharmaceutical market in the future, the government is also working to reduce long regulatory processes faced by pharmaceutical industry in order to expedite......"
13-Feb-2017$1995

Partnerships, Licensing, Investments and M&A Deals and Trends for December 2016 in Pharmaceuticals

By GlobalData
"...... ysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and vent......"
10-Feb-2017$1000

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Russia

By GlobalData
"...... GR) of 13%. For pharmaceutical companies hoping to profit from the Russian market in coming years, the country's increasing focus on biotechnology may provide ample opportunity. In 2012, the government adopted the Comprehensive Program for Developmen......"
09-Feb-2017$1995

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

By GlobalData
"...... 's robust public health insurance system and rising elderly population, increasing pressure on pharmaceutical selling prices, patent expiration of branded drugs and foreign exchange fluctuations are stifling growth. The government is currently focusi......"
07-Feb-2017$1995

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2017

By Current Partnering
"...... healthcare companies. Description The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented acces......"
01-Feb-2017$2995